CNS Summit 2024
At the 2024 CNS Summit, NeuroKaire showcased its innovative approach to precision psychiatry. Highlights included two poster presentations on our collaborations with Neurosense and Clexio, as well as a presentation in the Neuroscience sessions on NeuroKaire’s broader platform and vision.
NeuroKaire was honored to participate in the 2024 CNS Summit, sharing insights on how our precision psychiatry platform is advancing mental health care and drug development.
During the Neuroscience sessions, David presented NeuroKaire’s broader approach, focusing on the potential of patient-derived neurons to revolutionize treatment and accelerate innovation in mental health care.
We also shared two posters highlighting our collaborations:
• Collaboration with Neurosense: Leveraging patient-derived neurons to uncover new pathways for treating neurodegenerative diseases.
• Collaboration with Clexio: Advancing the use of biomarkers to predict antidepressant response and improve clinical outcomes.
The CNS Summit was an incredible opportunity to engage with thought leaders, showcase our work, and explore new collaborations. We’re excited to continue driving innovation in neuroscience and precision medicine.
Schedule a Meet & Greet
Contact Us
78 John Miller Way,
Kearny, NJ 07032, USA
Yigal Alon Street 126
Tel Aviv-Yafo, Israel